SCHEMBL4506846

SCHEMBL4506846

CCCCOC1C=CC=CO1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28362081 0.77 HIF1A (0.30)
SCHEMBL30310834 0.76
SCHEMBL715967 0.76
SCHEMBL11354669 0.74 SLC2A1 (0.41)
SCHEMBL9626973 0.73
SCHEMBL10430863 0.73 ALDH1A1 (0.30)
SCHEMBL9649968 0.73 ALDH1A1 (0.41)
SCHEMBL9349887 0.73 GBA1 (0.39) GBA1
SCHEMBL4496772 0.69 GBA1 (0.31) GBA1
SCHEMBL8973913 0.69 TDP1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7518003-B2 Production process of tetrahydropyran compound and tetrahydropyran compound produced by the production process SHOWA DENKO K.K. (JP) 2009-04-14 US disclosed
US-20080139828-A1 Reacting 3,4-dihydro-2-alkoxy-2H-pyran with hydrogen in the presence of a catalyst under acidic condition; Grignard reaction solvent or polymer solvent SHOWA DENKO K.K. (JP) 2008-06-12 US disclosed
CN-101068800-A Method for producing tetrahydropyran compound and tetrahydropyran compound produced by the production method SHOWA DENKO KK (JP) 2007-11-07 CN disclosed
EP-1828158-A1 PRODUCTION PROCESS OF TETRAHYDROPYRAN COMPOUND AND TETRAHYDROPYRAN COMPOUND PRODUCED BY THE PRODUCTION PROCESS SHOWA DENKO KABUSHIKI KAISHA (JP) 2007-09-05 EP disclosed
WO-2006062211-A1 PRODUCTION PROCESS OF TETRAHYDROPYRAN COMPOUND AND TETRAHYDROPYRAN COMPOUND PRODUCED BY THE PRODUCTION PROCESS SHOWA DENKO K.K. (JP) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139828-A1 Reacting 3,4-dihydro-2-alkoxy-2H-pyran with hydrogen in the presence of a catalyst under acidic condition; Grignard reaction solvent or polymer solvent HPD, ACR, GRHPR GBA1 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.